Answers are grounded in this paper and cite their sources.
To evaluate the maternal and fetal effects of ergot alkaloids and 5-hydroxytryptophan (5-HTP) consumed during gestation, pregnant ewes carrying twins were randomly assigned to one of three treatments: 1) negative control (CON, n = 10), 2) 5HTP (2.5 mg/kg BW) and toxic tall fescue seed containing 1.77 mg ewe-1 d-1 ergovaline/ergovalinine (E+/5-HTP, n = 10), or 3) positive control, fed toxic tall fescue seed containing 1.77 mg ewe-1 d-1 ergovaline/ergovalinine (E+, n = 10). Ewes were individually fed TMR plus treatment (CON, E+/5-HTP, or E+) at 2.5% of body weight from gestation d (gd) 86 to d 111. On d 111, a terminal necropsy was performed on the ewes to collect placental weights, fetal measurements, and fetal liver tissue for metabolomics analyses. Dry matter intake did not differ between E+/5-HTP or E+ versus CON and averaged 2.48% BW. Average daily gain did not differ between E+/5-HTP or E+ versus CON and averaged 0.304 kg/d during this study. Serum glucose and plasma insulin concentrations in ewes at gd85 and gd111 did not differ by treatment. Serum NEFA concentrations were greater (P < 0.05) for CON than E+/5-HTP or E+ on gd111 but did not differ on gd85. Plasma IL-6, a proinflammatory cytokine, concentration was greater (P < 0.05) in E+ ewes compared to CON on gd85. Gravid uterus weight per ewe was lower (P < 0.05) for E+ compared to CON. Exposure to ergovaline (E+) during gestation reduced (P = 0.036) total fetal weight per ewe compared to CON; however, total fetal weight per ewe did not differ with supplementation of 5-HTP (E+/5-HTP) compared to CON. Total placentome number and weight did not differ between treatments. Individual fetal weight was greater (P = 0.0033) for CON than E+; however, fetal weight did not differ (P = 0.22) between CON and E+/5-HTP. Fetal heart weight was lower (P = 0.013) for E+ compared to CON and tended to be lower (P = 0.052) for E+/5-HTP than CON. Fetal liver weight was greater (P < 0.05) for CON than E+ or E+/5-HTP. Fetal kidney and pancreas weights tended to be lower (P < 0.10) for E+ compared to CON but did not differ (P > 0.10) between E+/5-HTP and CON. Metabolomic analyses of fetal liver showed that E+ exposure during fetal liver development up-regulated 190 and down-regulated 628 metabolites compared to CON involved in biosynthesis of secondary compounds and amino acids. E+/5-HTP fetal livers had 407 up- and 55 down-regulated metabolites compared to E+ which included metabolic pathways and biosynthesis of secondary compounds. Supplementation of 5-HTP to pregnant ewes fed toxic tall fescue (E+) seed mitigated the negative effects of E+ on maternal oxidative stress, and fetal growth and organ development.
No takes yet. Share an insight, caveat, or question.
Duckett et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: